Advair Diskus 100/50 mcg Inhalation Powder
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Advair Diskus 100/50 mcg Inhalation Powder, covering 2020-07-07 to 2023-03-01. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence With Clinical Endpoint Study of Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma [Phase 3]